Filing Details

Accession Number:
0001209191-23-052803
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-13 19:59:08
Reporting Period:
2023-10-11
Accepted Time:
2023-10-13 19:59:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Medical Laboratories (8071) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1564777 Everett Cunningham C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-01 709 $30.02 23,412 No 5 A Direct
Common Stock Acquisiton 2023-10-11 20,003 $0.00 43,415 No 4 M Direct
Common Stock Acquisiton 2023-10-11 7,501 $0.00 50,916 No 4 M Direct
Common Stock Disposition 2023-10-12 13,007 $66.49 37,909 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-10-11 20,003 $0.00 20,003 $0.00
Common Stock Restricted Stock Units Disposition 2023-10-11 7,501 $0.00 7,501 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,004 No 4 M Direct
7,501 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 269 Indirect Held in 401(k) Plan
Footnotes
  1. Represents shares of common stock purchased through Employee Stock Purchase Plan.
  2. Represents shares of common stock received upon vesting of a restricted stock unit award.
  3. Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan, entered into September 21, 2021, to pay withholding taxes due in connection with the vesting of certain restricted stock units on October 11, 2023.
  4. In addition to the shares of Common Stock reported on this Form 4, which total 38,178 shares, Mr. Cunningham also holds, in the aggregate, an additional 71,707 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  5. Each restricted stock unit represents a contingent right to receive one share of common stock.
  6. Represents a restricted stock unit award that partially vested on October 11, 2023. The restricted stock units vest in three equal annual installments beginning on October 11, 2022.
  7. Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024.